- India's Hepatitis C Virus Drug Market Will Grow to More than $171 ... - PR Newswire (press release)
- RANBAXY COMPLETES PHASE II TRIALS FOR ANTI-MALARIA DRUG - Trading Markets (press release)
- Biosimilar G-CSF: Cooperation on Three Continents. - PR Newswire UK (press release)
- Ranbaxy completes phase II trials for anti-malaria drug - Expressindia.com
- Light Sciences Oncology Completes Patient Enrollment in Phase 3 ... - PR Newswire (press release)
Malaria: New Treatment is Upcoming - PR Newswire (press release)
Malaria: New Treatment is UpcomingPR Newswire (press release), NY - 6 hours agoThe most important trials in the program were two large phase III comparative clinical trials conducted in Africa (Burkina Faso, Zambia, Kenya, ...
